Lisa A. Jackson is an internist and infectious disease epidemiologist who has spent the past 20 years conducting clinical and epidemiologic studies of vaccine safety and efficacy.
In addition to her role as a senior scientific investigator at Group Health Research Institute (GHRI), she is a research professor in the University of Washington (UW) Department of Epidemiology and an adjunct research professor in the UW Department of Medicine
Dr. Jackson is the principal investigator (PI) at Group Health of the Vaccine Safety Datalink Project sponsored by the Centers for Disease Control and Prevention. She is also PI of the Vaccine and Treatment Evaluation Unit hosted by GHRI, one of eight such facilities nationwide that are sponsored by the National Institutes of Health.
Dr. Jackson has authored more than 140 peer-reviewed publications and 14 book chapters. She is a past member of the Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee and the National Vaccine Advisory Committee.
Dr. Jackson received her medical degree from the University of Virginia School of Medicine, Charlottesville, and her master of public health degree from the University of Washington School of Public Health and Community Medicine.
Vaccine safety; influenza vaccine effectiveness in the elderly; methodologic issues in vaccine effectiveness evaluations; pneumococcal polysaccharide vaccine effectiveness; pneumococcal conjugate vaccine immunogenicity in the elderly; epidemiology of E. coli bacteremia; epidemiology of community-acquired pneumonia
Stratton KG, Cook AJ, Jackson LA, Nelson JC.Simulation study comparing exposure matching with regression adjustment in an observational safety setting with group sequential monitoring.
Stat Med. 2014 Dec 15. doi: 10.1002/sim.6398. [Epub ahead of print]. PubMed
Jackson ML, Peterson D, Nelson JC, Greene SK, Jacobsen SJ, Belongia EA, Baxter R, Jackson LA.Using winter 2009-2010 to assess the accuracy of methods which estimate influenza-related morbidity and mortality.
Epidemiol Infect. 2014 Dec 12:1-9. [Epub ahead of print].
McLean HQ, Thompson MG, Sundaram ME, Kieke VA, Gaglani M, Murthy K, Piedra PA, Zimmerman RK, Nowalk MP, Raviotta JM, Jackson ML, Jackson L, Ohmit SE, Petrie JG, Monto AS, Meece JK, Thaker SN, Clippard JR, Spencer SM, Fry AM, Belongia EA.Influenza vaccine effectiveness in the United States during 2012-13: variable protection by age and virus type.
J Infect Dis. 2014 Nov 18. pii: jiu647. [Epub ahead of print]. PubMed
Callahan ST1, Wolff M2, Hill HR2, Edwards KM3; NIAID Vaccine and Treatment Evaluation Unit (VTEU) Pandemic H1N1 Vaccine Study Group.Impact of body mass index on immunogenicity of pandemic H1N1 vaccine in children and adults.
J Infect Dis. 2014 Oct 15;210(8):1270-4. doi: 10.1093/infdis/jiu245. Epub 2014 May 1. PubMed
Washington Post, Sep. 29, 2014